欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号AT/H/0583/001
药品名称Clozapin Accord 25 mg Tabletten
活性成分
    • clozapine 25.0 mg
剂型Tablet
上市许可持有人Accord Healthcare B.V. Winthontlaan 200, 3526KV Utrecht Niederlande ÜBER Accord Healthcare Lim., UK
参考成员国 - 产品名称Austria (AT)
Clozapin Accord 25 mg Tabletten
互认成员国 - 产品名称
    • Malta (MT)
      Clozapine Accord 25mg tablets
    • Denmark (DK)
      Clozapine "Accord"
    • Netherlands (NL)
      Cloozapine Accord
    • France (FR)
    • Italy (IT)
    • Sweden (SE)
    • Finland (FI)
    • Poland (PL)
      Clopizam
    • Estonia (EE)
      CLOZAPINE ACCORD
    • Cyprus (CY)
      CLOZAPINE ACCORD 25MG TABS
    • Slovakia (SK)
      Clozapine Accord 25 mg tablety
    • Spain (ES)
    • Germany (DE)
      Clozapin Accord 25 mg Tabletten
    • Croatia (HR)
    • Norway (NO)
    • Lithuania (LT)
      Clozapine Accord 25 tabletės
    • Latvia (LV)
      Clozapine Accord 25 mg tabletes
许可日期2017/01/18
最近更新日期2024/04/09
药物ATC编码
    • N05AH02 clozapine
申请类型
  • TypeLevel1：Known Active Substance
  • TypeLevel2：Initial Application
  • TypeLevel3：Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4：Chemical Substance
  • TypeLevel5：Prescription Only
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase